AMGEN INC — Proxy Solicitation & Information Statement 2020

Apr 7, 2020

DEFA14A 1 d907305ddefa14a.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

☑ Filed by the registrant ☐ Filed by a party other than the registrant

Check the appropriate box:
☐	Preliminary Proxy Statement
☐	CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2))
☐	Definitive Proxy Statement
☑	Definitive Additional Materials
☐	Soliciting Material Pursuant to Section 240.14a-12

AMGEN INC.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of filing fee (check the appropriate box): — ☑	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or
other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

SAMPLE

* Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on May 19, 2020 at 11:00 A.M., Pacific Time.

AMGEN INC.	Meeting Information — Meeting Type: For holders as of:	Annual Meeting March 20, 2020
	Date: May 19, 2020	Time: 11:00 A.M., Pacific Time
	Location:	Meeting will be held
solely by remote communication via the Internet-please visit www.virtualshareholdermeeting.com/AMGN2020.
	In light
of the ongoing developments related to the COVID-19 pandemic, the company will be hosting the meeting solely by remote communication via the Internet. To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/AMGN2020
and be sure to have the information that is printed in the box marked by the arrow (located on the following page).
AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320-1799 ATTN: SECRETARY	You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these shares. This communication
presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the
proxy materials before voting.
	See the reverse side of this notice to obtain proxy materials and voting
instructions.

Before You Vote

How to Access the Proxy Materials

Proxy Materials Available to VIEW or RECEIVE:
NOTICE OF 2020 ANNUAL MEETING PROXY STATEMENT 2019 ANNUAL REPORT
FORM PROXY CARD
How to View Online: Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge
for requesting a copy. Please choose one of the following methods to make your request:
1)	BY INTERNET :	www.proxyvote.com
2)	BY TELEPHONE :	1-800-579-1639
3)	BY E-MAIL* :	sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the
arrow (located on the following page) in the subject line.
Requests, instructions and
other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 5, 2020 to facilitate timely delivery.

How To Vote

Please Choose One of the Following Voting Methods

	Vote By Internet:
	Before The Meeting:
●	Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.
	During The Meeting:
	Go to www.virtualshareholdermeeting.com/AMGN2020. Have the information that is printed in
the box marked by the arrow (located on the following page) available and follow the instructions.
	Vote By Mail: You can vote by mail by requesting a paper copy of the
materials, which will include a proxy card.

Voting Items
The Board of Directors recommends you
vote "FOR" each listed nominee in item #1.

| | To elect eleven directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2021 annual meeting of
stockholders. The nominees for election to the Board of Directors are: — 1a. | Dr. Wanda M. Austin |
| --- | --- | --- |
| | 1b. | Mr. Robert A. Bradway |
| | 1c. | Dr. Brian J. Druker |
| | 1d. | Mr. Robert A. Eckert |
| | 1e. | Mr. Greg C. Garland |
| | 1f. | Mr. Fred Hassan |
| | 1g. | Mr. Charles M. Holley, Jr. |
| ● | 1h. | Dr. Tyler Jacks |
| | 1i. | Ms. Ellen J. Kullman |
| | 1j. | Dr. Ronald D. Sugar |
| | 1k. | Dr. R. Sanders Williams |

The Board of Directors recommends you vote “FOR” each of items #2 and #3.

1. Advisory vote to approve our executive compensation.

2. To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2020.

The Board of Directors recommends you vote “AGAINST” the Stockholder Proposal in item #4.

1. Stockholder proposal to require an independent board chair.

NOTE: Such other business as may properly come before the meeting or any continuation, postponement, or adjournment thereof.